Award-winning investigative reporter Katherine Eban's work has appeared in the New York Times and The New Yorker. Her first book, Dangerous Doses, exposes the exploits of pharmaceutical drug counterfeiters and polluters. On page 32, she explores the technology recently developed to bolster national security. She notes that "as a country we've spent billions on high-tech security gizmos and helpmates in the war on terror with much less information about whether those gizmos work, and whether our approach is making us safer." Eban's reporting on Biosense was funded in part by The Nation Institute.
Since 1998, Daniel Zimmerman has been the senior vice president of cellular immunology research at Cel-Sci Corporation, a biotech company based in Arlington, Va. He holds a PhD in biochemistry and has served as a guest worker for the NIH and NCI, while also producing more than 50 publications and US patents in immunology. This month's feature ...
